![Frontiers | HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience Frontiers | HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience](https://www.frontiersin.org/files/Articles/717792/fonc-11-717792-HTML/image_m/fonc-11-717792-g001.jpg)
Frontiers | HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience
![Glioblastoma: Current Status, Emerging Targets, and Recent Advances | Journal of Medicinal Chemistry Glioblastoma: Current Status, Emerging Targets, and Recent Advances | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c01946/asset/images/large/jm1c01946_0084.jpeg)
Glioblastoma: Current Status, Emerging Targets, and Recent Advances | Journal of Medicinal Chemistry
![JCM | Free Full-Text | Evolution of Radiation Therapy in Pancreas Cancer Management toward MRI-Guided Adaptive Radiation Therapy JCM | Free Full-Text | Evolution of Radiation Therapy in Pancreas Cancer Management toward MRI-Guided Adaptive Radiation Therapy](https://pub.mdpi-res.com/jcm/jcm-11-05380/article_deploy/html/images/jcm-11-05380-g001.png?1663315494)
JCM | Free Full-Text | Evolution of Radiation Therapy in Pancreas Cancer Management toward MRI-Guided Adaptive Radiation Therapy
![IJMS | Free Full-Text | Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition IJMS | Free Full-Text | Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition](https://pub.mdpi-res.com/ijms/ijms-21-04392/article_deploy/html/images/ijms-21-04392-g001.png?1592632191)
IJMS | Free Full-Text | Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition
![Frontiers | High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion Frontiers | High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion](https://www.frontiersin.org/files/Articles/810263/fonc-12-810263-HTML-r5/image_m/fonc-12-810263-g001.jpg)
Frontiers | High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion
![Frontiers | Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy Frontiers | Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy](https://www.frontiersin.org/files/Articles/533472/fcell-08-00325-HTML/image_m/fcell-08-00325-g001.jpg)
Frontiers | Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy
![An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma | Eye An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma | Eye](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41433-021-01766-w/MediaObjects/41433_2021_1766_Fig1_HTML.png)